<DOC>
	<DOCNO>NCT01429779</DOCNO>
	<brief_summary>The aim study accelerate recovery liver surgery enhance intestinal passage preoperative use Movicol . Hypothesis The use Movicol® one week prior partial liver resection combine Enhanced Recovery After Surgery ( ERAS® ) programme accelerate functional recovery promote early return gastro-intestinal function , define passage stool early oral intake .</brief_summary>
	<brief_title>The Orange-III Trial : Optimised Recovery With Movicol® Preoperatively Within Enhanced Recovery Programme</brief_title>
	<detailed_description>Rationale : The routine use laxatives liver surgery part Enhanced Recovery After Surgery ( ERAS® ) programme enhances recovery gastro-intestinal function early tolerance oral nutrition . The use Macrogol ( Movicol® ) laxative one week prior partial liver resection enhance early return gastro-intestinal function accelerate functional recovery . Objective : The aim study accelerate recovery liver surgery enhance intestinal passage preoperative use Movicol® Study design : The Orange-III trial multicentre randomise control trial aim whether administration 1 sachet Movicol® one week preoperatively 2 sachet Movicol® postoperatively enhance early recovery compare administration 2 sachet Movicol® postoperatively , follow liver surgery . All patient manage within ERAS® programme perioperative care . Study population : Patients require partial liver resection ( two segment ) , 18-80 yr old . Main study parameters/endpoints : The main objective Orange-III trial provide evidence early recovery gastro-intestinal function define time first intake solid food continue 24 hour use Movicol® one week prior partial liver resection within enhanced recovery programme . Secondary objective recovery gastro-intestinal function define time first stools time continuous intake clear fluid 24 hour , functional recovery , hospital length stay patient activity level .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<criteria>Patients undergo partial liver resection Able understand nature study require Men nonpregnant , nonlactating woman age 1880 BMI 1835 Patients ASA IIII Inability give write informed consent Patients require bile duct reconstruction Patients ASA IVV Superextended hepatectomy Underlying symptomatic liver disease cirrhosis Underlying gastrointestinal disease motility disorder Need procedure additive partial liver resection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>General surgery</keyword>
</DOC>